---
title: 'Director, Field Operations at Definium Therapeutics'
canonical: 'https://feeny.ai/job/director-field-operations-definium-therapeutics-remote-03sqbsdm57aa'
type: 'job'
last_seen: '2026-10-27'
---

# Director, Field Operations at Definium Therapeutics

- **Company:** Definium Therapeutics
- **Location:** Remote
- **Compensation:** $190k–$240k
- **Work type:** remote
- **Posted:** 2026-10-21
- **Last confirmed live:** 2026-10-27
- **Apply:** https://job-boards.greenhouse.io/definiumtherapeutics/jobs/6231469004

## Job description

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.

Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.

Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.

Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!

We are seeking a Director, Field Operations, to build and lead the operational capabilities that enable Definium’s first anticipated commercial launch. This hands-on leader will translate commercial strategy into reliable field processes, technology, governance, and execution across customer-facing commercial teams.

The role will own day-to-day field operations infrastructure—including territory and roster administration, targeting deployment, CRM business processes, field reporting, incentive compensation administration, and launch support—while partnering with Commercial Analytics on methodology and insights, Field Strategy on deployment design, and IT on enterprise technology architecture and implementation. The ideal candidate thrives in a lean, fast-moving biotech environment and can scale processes from pre-launch through commercialization.

Responsibilities:

- Develop and execute the field operations roadmap, launch milestones, SOPs, governance, service levels, and escalation processes.
- Coordinate onboarding, system access, equipment, training logistics, roster management, and operational support with HR, IT, Sales leadership, and vendors
- Operationalize field force designs, territory alignments, HCP/HCO affiliations, account hierarchies, target lists, call plans, and launch-wave transitions
- Serve as commercial business owner for Veeva Vault CRM field workflows, requirements, UAT, releases, adoption, and support in partnership with IT and Data Strategy
- Ensure operational data integrity across accounts, affiliations, assignments, and field activity; implement automation and approved AI-enabled workflows to improve efficiency
- Lead IC administration, eligibility, goal-setting operations, payout validation, dispute resolution, governance, documentation, and field communications
- Partner with Commercial Analytics on targeting, segmentation, sizing inputs, KPI definitions, dashboards, performance reporting, and operating reviews
- Partner with Sales, Market Access, Finance, HR, IT, Legal, Compliance, and Analytics to ensure coordinated execution, operational controls, IC plan approvals, and change management
- Oversee field operations vendors, budgets, deliverables, and service quality while establishing standardized processes, documentation, business continuity plans, and scalable operations to support launch and future growth

Qualifications:

- Minimum bachelor’s degree required, degree in business, life sciences, analytics, healthcare, or a related field preferred
- Minimum 10 years of related work experience required
- Progressive pharmaceutical, biotech, or life sciences experience in commercial operations, sales operations, or field force effectiveness
- Pre-launch or launch execution experience, ideally in specialty or complex therapeutics
- Hands-on experience with CRM operations (ie Veeva Vault CRM, Veeva data products, Salesforce, Power BI, Tableau) territory management, targeting deployment, call planning, incentive compensation, field reporting, and operational governance
- Ability to translate strategy into executable processes, system requirements, controls, and measurable operating outcomes
- Strong cross-functional leadership, vendor management, communication, analytical judgment, and project management skills
- Working knowledge of pharmaceutical compliance and data privacy requirements affecting field operations
- Experience with HCP/HCO account hierarchies, account-based field teams, reimbursement support models and specialty pharmacy or hub related field interfaces preferred
- Experience with incentive compensation governance, alignment platforms, field deployment waves, automation, or approved AI use cases preferred
- Up to 10% travel will be required based up business needs

Individual compensation within the range is determined based on factors such as relevant skills, experience, qualifications, scope of the role, and other legitimate business considerations.  In addition to base salary, this role may be eligible for bonus and equity opportunities. We also offer a comprehensive benefits package including health insurance, 401(k) with company match, flexible time off and additional wellness benefits and perks.  Learn more about our benefits on our Careers page.

The anticipated base salary range for this position is: $190,000—$240,000 USD

## About Definium Therapeutics

## Company Overview
- **One-liner**: Definium Therapeutics is a clinical-stage biopharmaceutical company applying scientific rigor to psychedelic medicine to develop accessible treatments for psychiatric disorders.
- **Entity Type**: Public (NASDAQ: DFTX)
- **Headquarters**: Not specified in available sources; the company operates as a remote-first organization.
- **Founded**: 2019 (originally as MindMed)
- **Founders**: Not publicly available in provided sources.

## Core Business
- **Primary Industry**: Biotechnology / Psychiatric drug development (psychedelic medicine)
- **Target Customers**: Patients with major depressive disorder (MDD), generalized anxiety disorder (GAD), posttraumatic stress disorder (PTSD), and autism spectrum disorder (ASD); also healthcare providers and payers.
- **Mission/Purpose**: “Unlock healing at scale” by harnessing the full therapeutic potential of psychedelic medicine through precise, evidence-based science.

## Products & Services
- **DT120 ODT (Lysergide/LSD D-Tartrate Oral Disintegrating Tablet)**: Investigational drug for GAD, MDD, and PTSD. Currently in four Phase 3 trials (Voyage, Panorama, Emerge, Ascend) and a fifth planned for PTSD. FDA Breakthrough Therapy Designation for GAD. No adjunctive psychotherapy required.
- **DT402 (R(-)-MDMA)**: R-enantiomer of MDMA selected for serotonergic properties with a potentially superior tolerability profile. In Phase 2a study for social communication challenges in autism spectrum disorder.

## Market Standing
- **Valuation/Market Cap**: Not publicly available (publicly listed on NASDAQ as DFTX as of 2026, but recent market cap not provided in search results).
- **Key Metric**: Pre-revenue clinical-stage company; total funding history not disclosed in available sources.
- **Notable Investors/Partners**: Not disclosed in provided sources.
- **Growth Signals**:
  - Five Phase 3 trials ongoing or planned for DT120 ODT.
  - FDA Breakthrough Therapy Designation for DT120 in GAD.
  - Phase 2a trial initiated for DT402 in ASD.
  - Full results from Phase 2b GAD trial published in JAMA (2025).
  - Strong intellectual property with issued patents covering formulation, manufacturing, and treatment.

## Competitive Advantages
- **Proprietary Formulations**: Pharmaceutically optimized ODT for LSD (DT120) and novel R-enantiomer of MDMA (DT402) with potential improved tolerability.
- **Scientific Rigor**: Standalone drug studies without psychotherapy, enabling clearer efficacy and safety data.
- **Regulatory Momentum**: FDA Breakthrough Therapy Designation and multiple IND clearances.
- **Experienced Management Team**: Proven track record in developing and commercializing CNS therapies.
- **Comprehensive IP Strategy**: Patents covering drug formulations, methods of manufacture, and treatment use.

## Strategic Focus
- **Late-Stage Pipeline Advancement**: Completing Phase 3 trials for GAD and MDD, initiating PTSD trial.
- **Pipeline Expansion**: Advancing DT402 for ASD and exploring additional neuropsychiatric indications.
- **Commercial Readiness**: Building infrastructure (hiring VP of Sales, Senior Director of Field VEOR, etc.) to support potential future launch.
- **Data Generation**: Generating high-quality evidence to support regulatory submissions and differentiation.

## Why Work Here
- **Remote-First Culture**: “You can live anywhere in the country you’re employed in” (remote-first workforce).
- **Comprehensive Benefits**: 100% paid medical, dental, vision for employees and dependents; FSA/HSA; life and disability insurance.
- **Wellness & Time Off**: Annual wellness allowance, flexible PTO, company-wide shutdowns for rest.
- **Family Support**: Paid parental leave for birthing and non-birthing parents, 2-week return-to-work transition.
- **Financial Wellness**: Competitive compensation, 401(k) with employer match, employee equity (new hire grants and refreshes), Employee Stock Purchase Plan (ESPP) with discount.
- **Mission-Driven Work**: Opportunity to contribute to groundbreaking treatments in psychedelic psychiatry with a science-driven, collaborative team.

## Sources
1. [definiumtx.com](https://definiumtx.com/) – Company overview and pipeline details
2. [definiumtx.com](https://definiumtx.com/story/) – Company history, leadership, and strategic milestones
3. [definiumtx.com](https://definiumtx.com/careers/) – Careers page with benefits and remote-first policy
4. [definiumtx.com](https://definiumtx.com/research-development/) – Research and development pipeline details
5. [linkedin.com](https://www.linkedin.com/company/definiumtherapeutics) – LinkedIn company page

## Other roles at Definium Therapeutics

- [Senior Clinical Trial Manager](https://feeny.ai/job/senior-clinical-trial-manager-definium-therapeutics-remote-wvrjhsw19grb)
- [Associate Director, Brand Counsel](https://feeny.ai/job/associate-director-brand-counsel-definium-therapeutics-remote-drzwb505czfs)
- [Associate Director, Medical Marketing](https://feeny.ai/job/associate-director-medical-marketing-definium-therapeutics-remote-eav95eymjzpf)
- [Manager, Data & Analytics](https://feeny.ai/job/manager-data-analytics-definium-therapeutics-remote-1myd7q4ncfyq)
- [Sr. Director, Sales Training](https://feeny.ai/job/sr-director-sales-training-definium-therapeutics-remote-4e05xqacax1x)
- [Director, Regulatory Affairs (Advertising and Promotions)](https://feeny.ai/job/director-regulatory-affairs-advertising-and-promotions-definium-therapeutics-yttv1kff5hzj)
- [Associate Director, Statistical Programming](https://feeny.ai/job/associate-director-statistical-programming-definium-therapeutics-remote-32hes91t3fd9)
- [Director, Supply and Distribution Quality](https://feeny.ai/job/director-supply-and-distribution-quality-definium-therapeutics-remote-6hf75zdnx5pq)
- [Director, Medical Communications](https://feeny.ai/job/director-medical-communications-definium-therapeutics-remote-35fwkadvgv4y)
- [Director, Patient Services Operations](https://feeny.ai/job/director-patient-services-operations-definium-therapeutics-raleigh-durham-b25ndrr3vznf) — Raleigh/durham, NC